HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Lv Selected Research

norisoboldine

3/2018Norisoboldine, a natural aryl hydrocarbon receptor agonist, alleviates TNBS-induced colitis in mice, by inhibiting the activation of NLRP3 inflammasome.
1/2018Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway.
12/2015Norisoboldine ameliorates DSS-induced ulcerative colitis in mice through induction of regulatory T cells in colons.
1/2015Norisoboldine, an Anti-Arthritis Alkaloid Isolated from Radix Linderae, Attenuates Osteoclast Differentiation and Inflammatory Bone Erosion in an Aryl Hydrocarbon Receptor-Dependent Manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Lv Research Topics

Disease

14Infections
12/2022 - 01/2011
14Neoplasms (Cancer)
06/2022 - 07/2012
12COVID-19
01/2022 - 01/2020
11Colitis
09/2021 - 12/2015
9Neoplasm Metastasis (Metastasis)
11/2021 - 07/2012
8Inflammation (Inflammations)
10/2021 - 01/2013
7Human Influenza (Influenza)
11/2019 - 12/2012
5Acute Kidney Injury (Acute Renal Failure)
12/2021 - 02/2016
5Ulcerative Colitis
09/2021 - 12/2015
5Virus Diseases (Viral Diseases)
09/2021 - 11/2010
5Lung Injury
01/2020 - 01/2016
4Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 01/2020
4Carcinogenesis
02/2021 - 01/2013
4Acute Lung Injury
01/2021 - 01/2014
4Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2018 - 01/2013
3Crush Injuries
02/2022 - 12/2020
3Crush Syndrome
12/2021 - 04/2020
3Weight Loss (Weight Reduction)
12/2019 - 01/2017
3Fibrosis (Cirrhosis)
01/2019 - 01/2013
3Pneumonia (Pneumonitis)
01/2019 - 01/2013
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2018 - 12/2015
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2016
2Coronavirus Infections
09/2021 - 12/2019
2Body Weight (Weight, Body)
01/2021 - 01/2019
2Edema (Dropsy)
04/2020 - 12/2018
2Hypoxia (Hypoxemia)
01/2020 - 01/2018
2Smoke Inhalation Injury
12/2018 - 07/2017
2Rheumatoid Arthritis
03/2016 - 11/2015
2Experimental Arthritis
12/2015 - 01/2015
2Arthritis (Polyarthritis)
11/2015 - 01/2015
1Colorectal Neoplasms (Colorectal Cancer)
12/2021
1Non-alcoholic Fatty Liver Disease
12/2021
1Glioblastoma (Glioblastoma Multiforme)
12/2021
1Nervous System Diseases (Neurological Disorders)
09/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
12/2022 - 12/2012
10Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2010
7CytokinesIBA
08/2021 - 01/2011
5Pharmaceutical PreparationsIBA
01/2022 - 01/2013
5Therapeutic UsesIBA
09/2021 - 01/2014
5Interleukin-6 (Interleukin 6)IBA
12/2020 - 01/2017
5MicroRNAs (MicroRNA)IBA
01/2020 - 01/2018
4Antiviral Agents (Antivirals)IBA
09/2021 - 01/2014
4InflammasomesIBA
09/2021 - 01/2018
4Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2020 - 01/2015
4ChemokinesIBA
08/2020 - 01/2011
42-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA
12/2019 - 01/2018
4norisoboldineIBA
03/2018 - 01/2015
4Dextran SulfateIBA
01/2018 - 12/2015
4Messenger RNA (mRNA)IBA
11/2016 - 05/2012
3Circular RNAIBA
12/2021 - 01/2020
3LigandsIBA
10/2021 - 11/2017
3Peroxidase (Myeloperoxidase)IBA
08/2021 - 01/2018
3DNA-Binding Proteins (DNA Binding Protein)IBA
01/2020 - 07/2012
3Neutralizing AntibodiesIBA
01/2020 - 01/2014
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2018 - 01/2013
3Hemagglutinins (Hemagglutinin)IBA
01/2016 - 11/2010
2EnzymesIBA
02/2022 - 10/2020
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
2LipidsIBA
01/2022 - 12/2021
2Fatty Acids (Saturated Fatty Acids)IBA
12/2021 - 01/2021
2RNA-Binding Proteins (RNA-Binding Protein)IBA
11/2021 - 12/2020
2CC ChemokinesIBA
10/2021 - 11/2017
2FlavonoidsIBA
09/2021 - 01/2021
2MyoglobinIBA
01/2021 - 04/2020
2Biological ProductsIBA
01/2021 - 01/2018
2InterferonsIBA
12/2020 - 08/2020
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2020 - 01/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2015
2alpinetinIBA
12/2019 - 01/2018
2AerosolsIBA
12/2019 - 11/2019
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2019 - 01/2018
2RNA (Ribonucleic Acid)IBA
01/2019 - 01/2015
2SmokeIBA
12/2018 - 01/2016
2CollagenIBA
12/2018 - 01/2013
2Oseltamivir (Tamiflu)FDA Link
11/2018 - 01/2015
2Sulfonic AcidsIBA
03/2018 - 01/2018
2AlkaloidsIBA
03/2018 - 01/2015
2Sirtuin 1IBA
01/2018 - 01/2017
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 04/2016
2FluorocarbonsIBA
07/2017 - 01/2014
1Monoclonal AntibodiesIBA
12/2022
1Peptide Hydrolases (Proteases)FDA Link
06/2022
1asparaginylendopeptidase (legumain)IBA
06/2022
1Bisoprolol (Concor)FDA LinkGeneric
02/2022
1Anesthetics (Anesthetic Agents)IBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1pexidartinibIBA
12/2021
1compound 21IBA
12/2021
1Sucrose (Saccharose)IBA
12/2021
1Glycoproteins (Glycoprotein)IBA
12/2021
1Dietary FiberFDA Link
12/2021
1Dietary Fats (Dietary Fat)IBA
12/2021
1CarbohydratesIBA
12/2021

Therapy/Procedure

8Therapeutics
06/2022 - 11/2019
2Oral Administration
08/2021 - 01/2017
2Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2016 - 11/2015
1Resuscitation
02/2022
1Immunotherapy
12/2021